Tenaya Therapeutics(TNYA)
SOUTH SAN FRANCISCO, CA
Biotechnology1 H-1B visas (FY2023)Focus: Cardiovascular Therapeutics
Tenaya Therapeutics is a life sciences company focused on Cardiovascular Therapeutics.
CardiovascularMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated
Arrhythmogenic Right Ventricular CardiomyopathyClinical Trials (1)
NCT06311708Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
N/ANatural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
CardiomyopathyClinical Trials (1)
NCT05112237Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
N/APhase 1
Clinical Trials (1)
NCT06228924Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Phase 1Phase 1/2
Clinical Trials (1)
NCT05836259Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Phase 1/2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 4 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 1 active job
Hiring Trend
Stable
1
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub